 |
|
| Blog results | Results 1 - 10 of about 215,448 for cancer + drugs + again. (0.37 seconds) |
| Sorted by relevance Sort by date |
| 2 Dec 2009 by Melissa Marino The disappointing results – again due to the fact that no two cancers are the same – highlight the importance of developing new anti-cancer drugs that will allow physicians more options in achieving truly personalized cancer care. ... VICC News & Publications - http://www.vicc.org/news/ |
| 2 Dec 2009 by Alice Rossiter Early research has demonstrated that MUC1* may play a role in developing resistance to cancer drugs, which means that if scientists can block MUC1*, patients may be able to overcome resistance to a drug and, once again, be offered that ... Cancer Drug News Editor's Blog - http://cancerdrugnewsblog.blogspot.com/ - References |
| 10 hours ago by CANCER Chemotherapy is the use of anti-cancer drugs that go throughout the entire body. These drugs may be given through a vein or as pills by mouth. Chemotherapy is recommended after surgery for some stage I and stage II non-small cell lung cancer ... Small cell lung cancer is very responsive to chemotherapy, and most patients with small cell lung cancer will be offered chemotherapy. Again, depending on the specifics of an individual case, it may be given during radiation, ... CANCER - http://badcancer.blogspot.com/ |
| 25 Nov 2009 ... is that leukemia cells can find a "safe haven" among fat cells, known as adipocytes, and ride out the storm of anti-cancer drugs doctors used to kill them. This could leave them free to flourish again once chemotherapy ends. ... Health & Fitness - http://www2.hernandotoday.com/content/list/life/health/ |
| 2 Dec 2009 by admin These drugs include tamoxifen and newer aromatase inhibitors like Arimidex. Women who haven't reached menopause may consider having their ovaries removed to stop them from making hormones that help cancer grow. Again, women with larger ... Healthy Women - http://healthy-women.bolady.com/ |
| 30 Nov 2009 by The Independent The trouble is that most put the weight on again later. Almost one million prescriptions for obesity drugs, such as Reductil (sibutramine) and Xenical (orlistat), are being written every year; orlistat can now be obtained without a ... Life and Style | The Independent UK - http://lifeandstyle.independentminds.livejournal.com/ - References |
| 7 hours ago by xxprincess ... but they use drugs and cigs as escapants..its the most common reason why ppl take drugs/alcohol/cigs sounds like you know nothing about smoking except thats its bad??? mate it isnt even proven smoking pot gives u lung cancer so shut ya mouth. ... u dont deserve to have a conversation with decent ppl cause u r not, learn to read, there is a coma, i said alcohol is bad, its organic (talking about weed again), so dont push urself in a conversation that u cant understand, ... XX Princess - http://xxprincess.net/ |
| 1 Dec 2009 by Julian Harris "20% higher than Europe" reported a recent headline, while new cancer drugs continue to be rationed, often considered "not cost effective". Now it's the turn of survival rates within the UK to throw up some shocking results, ... IPN Health Blog - http://policynetwork.blogs.com/fightingdiseases/ |
| 15 hours ago Bayer and Johnson & Johnson's rivaroxaban will go before the FDA once again in early 2010, seeking approval for the treatment of venous thromboembolism post-surgery. This follows an approvable letter in May 2009. ... In particular, monoclonal antibodies are gaining market share, with six antibodies now appearing in the top 15 drugs of 2010 by sales. Targeted therapies are changing the cancer market and are expected to be used in most cancer patients within five years. ... Pharmaceutical Executive Magazine - http://pharmexec.findpharma.com/pharmexec |
| 4 Nov 2009 by Trista Morrison Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice? By Trista Morrison | Nov 4, 2009. The most surprising thing about last week's Phase III failure of beleaguered cancer drug Genasense was that Genta's stock (GETA. ... March 2008: FDA denies CLL appeal and maintains that more data is needed; Genta reanalyzes data and tries again; Dec 2008: FDA denies CLL approval again; Genta decides to appeal again; March 2009: FDA rejects second CLL appeal ... Pharma Analysis RSS | BNET Industries - http://industry.bnet.com/pharma/blog/feed/rss/ - References [ More results from Pharma Analysis RSS | BNET Industries ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
